Naicker, Nivashnee
Yende-Zuma, Nonhlanhla
Kharsany, Ayesha B. M.
Shozi, Hlengiwe
Nkosi, Duduzile
Naidoo, Anushka
Garrett, Nigel
Abdool Karim, Salim S.
Article History
Received: 11 February 2022
Accepted: 14 June 2022
First Online: 26 July 2022
Declarations
:
: The CAPRISA 002 study was reviewed and approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (E013/04). All methods were carried out in accordance with relevant guidelines and regulations. All study participants provided written informed consent at study entry.
: Not applicable.
: The authors declare that they have no competing interests. AN is supported by National Institutes of Health (NIH) grants K43TW011437 and 1R01 AI152142-01.